The plasma membrane permese PfNT1 is essential for purine salvage in the human malaria parasite Plasmodium falciparum

Proceedings of the National Academy of Sciences of the United States of America

Volumn 103, Issue 24, 2006, Pages 9286-9291

  El Bissati, Kamal ^a   Zufferey, Rachel ^a   Witola, William H ^a   Carter, Nicola S ^b   Ullman, Buddy ^b   Ben Mamoun, Choukri ^a  

^a UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

Conditional knockout; Sequential pathway; Transporter

Indexed keywords

ADENOSINE; CELL MEMBRANE PROTEIN; HYPOXANTHINE; INOSINE; NUCLEOSIDE TRANSPORTER; PERMEASE; PROTEIN PFNT1; PURINE; UNCLASSIFIED DRUG; CARRIER PROTEIN; NT1 PROTEIN, PLASMODIUM FALCIPARUM; PROTOZOAL PROTEIN; PURINE DERIVATIVE;

ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; ERYTHROCYTE; LETHAL MUTANT; NONHUMAN; NUTRIENT; PHENOTYPE; PLASMODIUM FALCIPARUM; PRIORITY JOURNAL; PROTEIN TRANSPORT; SURVIVAL; TRANSGENE; VALIDATION PROCESS; ANIMAL; CELL MEMBRANE; CHEMISTRY; CULTURE MEDIUM; ENZYMOLOGY; GENE TARGETING; GENETICS; HUMAN; METABOLISM; PARASITOLOGY; TRANSGENIC ANIMAL;

PLASMODIUM FALCIPARUM;

ANIMALS; ANIMALS, GENETICALLY MODIFIED; CELL MEMBRANE; CULTURE MEDIA; ERYTHROCYTES; GENE TARGETING; HUMANS; MEMBRANE TRANSPORT PROTEINS; PHENOTYPE; PLASMODIUM FALCIPARUM; PROTOZOAN PROTEINS; PURINES;

EID: 33745131759     PISSN: 00278424     EISSN: None     Source Type: Journal    
DOI: 10.1073/pnas.0602590103     Document Type: Article

References (22)

1. World Health Organization (2000) WHO Tech. Rep. Ser. 892, 1-74.
2. Gero, A. M. & O'Sullivan, W. J. (1990) Blood Cells 16, 467-484; discussion 485-498.
3. Sherman, I. W. (1998) in Malaria: Parasite Biology, Pathogenesis, and Protection, ed. Sherman, I. W. (Am. Soc. Microbiol., Washington, DC), pp. 177-184.
4. Sherman, I. W. (1979) Microbiol. Rev. 43, 453-495.
5. Gero, A. M. & Upston, J. M. (1994) Adv. Exp. Med. Biol. 370, 493-498.
6. Upston, J. M. & Gero, A. M. (1995) Biochim. Biophys. Acta 1236, 249-258.
7. Boleti, H., Coe, I. R., Baldwin, S. A., Young, J. D. & Cass, C. E. (1997) Neuropharmacology 36, 1167-1179.
8. Carter, N. S., Ben Mamoun, C., Liu, W., Silva, E. O., Landfear, S. M., Goldberg, D. E. & Ullman, B. (2000) J. Biol. Chem. 275, 10683-10691.
9. Rager, N., Ben Mamoun, C., Carter, N. S., Goldberg, D. E. & Ullman, B. (2001) J. Biol. Chem. 276, 41095-41099.
10. Parker, M. D., Hyde, R. J., Yao, S. Y., McRobert, L., Cass, C. E., Young, J. D., McConkey, G. A. & Baldwin, S. A. (2000) Biochem. J. 349, 67-75.
11. Duraisingh, M. T., Triglia, T. & Cowman, A. F. (2002) Int. J. Parasitol. 32, 81-89.
12. Ben Mamoun, C., Gluzman, I. Y., Goyard, S., Beverley, S. M. & Goldberg, D. E. (1999) Proc. Natl. Acad. Sci. USA 96, 8716-8720.
13. Santiago, T. C., Zufferey, R., Mehra, R. S., Coleman, R. A. & Ben Mamoun, C. (2004) J. Biol. Chem. 279, 9222-9232.
14. Traut, T. W. (1994) Mol. Cell. Biochem. 140, 1-22.
15. Carter, N. S., Landfear, S. M. & Ullman, B. (2001) Trends Parasitol. 17, 142-145.
16. Daddona, P. E. & Kelley, W. N. (1977) J. Biol. Chem. 252, 110-115.
17. Lewis, A. S. & Lowy, B. A. (1979) J. Biol. Chem. 254, 9927-9932.
18. Yamada, K. A. & Sherman, I. W. (1981) Mol. Biochem. Parasitol. 2, 349-358.
19. Kirk, K. (2001) Physiol. Rev. 81, 495-537.
20. Martin, R. E., Henry, R. I., Abbey, J. L., Clements, J. D. & Kirk, K. (2005) Genome Biol. 6, R26.
21. Trager, W. & Jensen, J. B. (1976) Science 193, 673-675.
22. Lambros, C. & Vanderberg, J. P. (1979) J. Parasitol. 65, 418-420.